Completed PHASE3 INTERVENTIONAL 2-arm NCT01984099

RCT on the Efficacy of Methotrexate for the Prevention of GTD

The Efficacy of Methotrexate for the Prevention of Postmolar Gestational Trophoblastic Disease Among Patients With High-Risk Hydatidiform Mole

Sponsor: University of the Philippines

Conditions Hydatidiform Mole

Interventions Methotrexate Vitamin B Complex

Updated 5 times since 2017 Last updated: Apr 16, 2020 Started: Dec 31, 2011 Primary completion: Aug 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hydatidiform Mole, this trial is completed. The trial is conducted by University of the Philippines and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
May 2020 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — May 2020 [monthly]

Completed PHASE3

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of the Philippines

Data source: University of the Philippines

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taft Avenue, Ermita, Manila, Philippines